Rockwell Medical RMTI
NASDAQ RMTI
$7.95 -0.11 (-1.30%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025)

Rockwell Medical's (RMTI) quarterly Total Non-Current Liabilities came in at $20.2 million in Q4 2025, down 21.3% on a YoY basis from $25.6 million in Q4 2024, and down 1.48% quarter-over-quarter from $20.5 million in Q3 2025.

Analysis

Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Rockwell Medical (RMTI) has reported Total Non-Current Liabilities for 11 consecutive years, with $20.2 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million; the trailing twelve-month figure through Dec 2025 stood at $20.2 million (down 21.3% YoY), and the FY2025 full-year result was $20.2 million, down 21.3% from the prior year.
  • Total Non-Current Liabilities declined to $20.2 million in Q4 2025 per RMTI's latest filing, from $20.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $46.0 million in Q4 2021 and bottomed at $19.5 million in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $29.4 million across 5 years, with a median of $27.9 million in 2023.
  • The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities climbed 5.62% in 2021, then slumped 33.89% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $46.0 million in 2021, then declined by 29.35% to $32.5 million in 2022, then decreased by 12.71% to $28.4 million in 2023, then dropped by 9.72% to $25.6 million in 2024, then slipped by 21.3% to $20.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $20.2 million, $20.5 million, and $22.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 23.92 Bn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 17.56 Bn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 996.30 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 12.41 Bn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn -89.27 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 75.19 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn -
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 13.70 Mn
9 United Health Products 9.09 Mn 9.06 Mn - 4.54 Mn
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - 333,758.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.16 Mn
Sep 30, 2025 20.47 Mn
Jun 30, 2025 22.22 Mn
Mar 31, 2025 19.54 Mn
Dec 31, 2024 25.62 Mn
Sep 30, 2024 26.20 Mn
Jun 30, 2024 27.03 Mn
Mar 31, 2024 27.58 Mn
Dec 31, 2023 28.38 Mn
Sep 30, 2023 28.59 Mn
Jun 30, 2023 28.50 Mn
Mar 31, 2023 27.92 Mn
Dec 31, 2022 32.52 Mn
Sep 30, 2022 38.04 Mn
Jun 30, 2022 38.96 Mn
Mar 31, 2022 42.23 Mn
Dec 31, 2021 46.03 Mn
Dec 31, 2020 43.58 Mn
Sep 30, 2014 25.11 Mn
Jun 30, 2014 25.57 Mn